According to a systemic review by Kapoula et al., urine KIM-1 could be considered to be a valuable biomarker for the early detection of DN in patients with type 2 diabetes mellitus (T2DM) [20]. The gene discussed is HAVCR1; the disease is type 2 diabetes mellitus.